247 related articles for article (PubMed ID: 29199015)
21. The impact of the 2005 International Society of Urological Pathology consensus guidelines on Gleason grading - a matched-pair analysis.
Berg KD; Thomsen FB; Nerstrøm C; Røder MA; Iversen P; Toft BG; Vainer B; Brasso K
BJU Int; 2016 Jun; 117(6):883-9. PubMed ID: 26823232
[TBL] [Abstract][Full Text] [Related]
22. [Impact of International Association of Urological Pathology Gleason scoring system on prostatic carcinoma grading: a preliminary analysis of 185 cases].
Wang G; Shen D
Zhonghua Bing Li Xue Za Zhi; 2014 Oct; 43(10):677-9. PubMed ID: 25567594
[TBL] [Abstract][Full Text] [Related]
23. Clear cell renal cell carcinoma: validation of World Health Organization/International Society of Urological Pathology grading.
Dagher J; Delahunt B; Rioux-Leclercq N; Egevad L; Srigley JR; Coughlin G; Dunglinson N; Gianduzzo T; Kua B; Malone G; Martin B; Preston J; Pokorny M; Wood S; Yaxley J; Samaratunga H
Histopathology; 2017 Dec; 71(6):918-925. PubMed ID: 28718911
[TBL] [Abstract][Full Text] [Related]
24. Extraprostatic Extension Is Extremely Rare for Contemporary Gleason Score 6 Prostate Cancer.
Anderson BB; Oberlin DT; Razmaria AA; Choy B; Zagaja GP; Shalhav AL; Meeks JJ; Yang XJ; Paner GP; Eggener SE
Eur Urol; 2017 Sep; 72(3):455-460. PubMed ID: 27986368
[TBL] [Abstract][Full Text] [Related]
25. The impact of the 2005 international society of urological pathology consensus conference on standard Gleason grading of prostatic carcinoma in needle biopsies.
Billis A; Guimaraes MS; Freitas LL; Meirelles L; Magna LA; Ferreira U
J Urol; 2008 Aug; 180(2):548-52; discussion 552-3. PubMed ID: 18550106
[TBL] [Abstract][Full Text] [Related]
26. Gleason grading: past, present and future.
Delahunt B; Miller RJ; Srigley JR; Evans AJ; Samaratunga H
Histopathology; 2012 Jan; 60(1):75-86. PubMed ID: 22212079
[TBL] [Abstract][Full Text] [Related]
27. Accuracy of prostate biopsies for predicting Gleason score in radical prostatectomy specimens: nationwide trends 2000-2012.
Danneman D; Drevin L; Delahunt B; Samaratunga H; Robinson D; Bratt O; Loeb S; Stattin P; Egevad L
BJU Int; 2017 Jan; 119(1):50-56. PubMed ID: 26918298
[TBL] [Abstract][Full Text] [Related]
28. Atypical Intraductal Cribriform Proliferations of the Prostate Exhibit Similar Molecular and Clinicopathologic Characteristics as Intraductal Carcinoma of the Prostate.
Hickman RA; Yu H; Li J; Kong M; Shah RB; Zhou M; Melamed J; Deng FM
Am J Surg Pathol; 2017 Apr; 41(4):550-556. PubMed ID: 28009609
[TBL] [Abstract][Full Text] [Related]
29. Predictive value of the 2014 International Society of Urological Pathology grading system for prostate cancer in patients undergoing radical prostatectomy with long-term follow-up.
Grogan J; Gupta R; Mahon KL; Stricker PD; Haynes AM; Delprado W; Turner J; Horvath LG; Kench JG
BJU Int; 2017 Nov; 120(5):651-658. PubMed ID: 28371244
[TBL] [Abstract][Full Text] [Related]
30. Modified Gleason grading. An updated review.
Helpap B; Egevad L
Histol Histopathol; 2009 May; 24(5):661-6. PubMed ID: 19283673
[TBL] [Abstract][Full Text] [Related]
31. [The 2014 consensus conference of the ISUP on Gleason grading of prostatic carcinoma].
Kristiansen G; Egevad L; Amin M; Delahunt B; Srigley JR; Humphrey PA; Epstein JI;
Pathologe; 2016 Feb; 37(1):17-26. PubMed ID: 26809207
[TBL] [Abstract][Full Text] [Related]
32. The reasons behind variation in Gleason grading of prostatic biopsies: areas of agreement and misconception among 266 European pathologists.
Berney DM; Algaba F; Camparo P; Compérat E; Griffiths D; Kristiansen G; Lopez-Beltran A; Montironi R; Varma M; Egevad L
Histopathology; 2014 Feb; 64(3):405-11. PubMed ID: 24102975
[TBL] [Abstract][Full Text] [Related]
33. Grading of prostate cancer: the impact of including intraductal carcinoma on the overall Grade Group assigned in diagnostic biopsies.
Chen-Maxwell D; Prendeville S
Histopathology; 2020 Sep; 77(3):503-507. PubMed ID: 32358793
[TBL] [Abstract][Full Text] [Related]
34. Recent advances in prostate cancer pathology: Gleason grading and beyond.
Shah RB; Zhou M
Pathol Int; 2016 May; 66(5):260-72. PubMed ID: 26991008
[TBL] [Abstract][Full Text] [Related]
35. Report From the International Society of Urological Pathology (ISUP) Consultation Conference on Molecular Pathology of Urogenital Cancers. I. Molecular Biomarkers in Prostate Cancer.
Lotan TL; Tomlins SA; Bismar TA; Van der Kwast TH; Grignon D; Egevad L; Kristiansen G; Pritchard CC; Rubin MA; Bubendorf L
Am J Surg Pathol; 2020 Jul; 44(7):e15-e29. PubMed ID: 32044806
[TBL] [Abstract][Full Text] [Related]
36. [International Society of Urological Pathology (ISUP) Consensus Conference on handling and staging of radical prostatectomy specimens].
Compérat E; Camparo P; Srigley J; Delahunt B; Egevad L;
Ann Pathol; 2013 Jun; 33(3):155-61. PubMed ID: 23790653
[TBL] [Abstract][Full Text] [Related]
37. International Society of Urological Pathology (ISUP)-Grade Grouping in Prostatic Adenocarcinoma and its Prognostic Implications.
Hashmi AA; Iftikhar SN; Munawar S; Ahmed O; Yaqeen SR; Asghar IA; Irfan M; Ali J; Edhi MM; Hashmi SK
Cancer Invest; 2022 Mar; 40(3):211-218. PubMed ID: 34907822
[TBL] [Abstract][Full Text] [Related]
38. Contemporary Gleason grading and novel Grade Groups in clinical practice.
Magi-Galluzzi C; Montironi R; Epstein JI
Curr Opin Urol; 2016 Sep; 26(5):488-92. PubMed ID: 27308734
[TBL] [Abstract][Full Text] [Related]
39. Utility of PTEN and ERG immunostaining for distinguishing high-grade PIN from intraductal carcinoma of the prostate on needle biopsy.
Morais CL; Han JS; Gordetsky J; Nagar MS; Anderson AE; Lee S; Hicks JL; Zhou M; Magi-Galluzzi C; Shah RB; Epstein JI; De Marzo AM; Lotan TL
Am J Surg Pathol; 2015 Feb; 39(2):169-78. PubMed ID: 25517949
[TBL] [Abstract][Full Text] [Related]
40. Histopathology of Prostate Cancer.
Humphrey PA
Cold Spring Harb Perspect Med; 2017 Oct; 7(10):. PubMed ID: 28389514
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
